| NCT06576843 | INDV-6001 Multiple-Dose Pharmacokinetic Study | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-09-17 | 2025-12 | 2025-12 |
| NCT06384157 | Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder | ACTIVE_NOT_RECRUITING | PHASE2 | 2024-06-10 | 2025-12 | 2025-11 |
| NCT05974046 | Single Dose Study of [14C]-IDV184001AN ([14C]-IDV184001) in Healthy Adult Male Participants | COMPLETED | PHASE1 | 2023-07-10 | 2023-07-21 | 2023-07-21 |
| NCT05694533 | Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults | COMPLETED | PHASE1 | 2023-03-16 | 2023-05-01 | 2023-04-06 |
| NCT05704543 | Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations | COMPLETED | PHASE4 | 2023-03-01 | 2023-11-01 | 2023-11-01 |
| NCT04976855 | Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder | COMPLETED | PHASE1 | 2022-08-17 | 2023-07-05 | 2023-07-05 |
| NCT04995029 | Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users | COMPLETED | PHASE4 | 2021-10-26 | 2024-06-26 | 2024-06-26 |
| NCT04413552 | INDV-2000 First in Human | COMPLETED | PHASE1 | 2020-07-06 | 2021-04-13 | 2021-04-13 |
| NCT04060654 | SUBLOCADE Rapid Initiation Extension Study | COMPLETED | PHASE4 | 2019-10-21 | 2020-05-15 | 2020-05-15 |
| NCT03993392 | SUBLOCADE Rapid Initiation Study | COMPLETED | PHASE4 | 2019-08-29 | 2019-12-26 | 2019-12-26 |
| NCT03978832 | Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone | COMPLETED | PHASE4 | 2019-06-28 | 2020-05-12 | 2020-05-12 |
| NCT03747341 | Buprenorphine-Fentanyl Interaction Study | COMPLETED | PHASE1 | 2018-03-22 | 2019-01-04 | 2019-01-04 |
| NCT03715634 | Study of a Novel Subcutaneous Depot Formulation of Buprenorphine | COMPLETED | PHASE1 | 2017-09-20 | 2018-06-07 | 2018-06-07 |
| NCT03058237 | A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy Volunteers | COMPLETED | PHASE1 | 2017-01-24 | 2017-07-05 | 2017-07-05 |
| NCT02896296 | Open-Label Treatment Extension Study | COMPLETED | PHASE3 | 2016-08-17 | 2017-08-23 | 2017-08-23 |
| NCT02687984 | PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia | COMPLETED | PHASE1 | 2016-02 | 2016-05 | 2016-05 |
| NCT02511886 | A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder | COMPLETED | PHASE2 | 2015-09 | 2016-01 | 2016-01 |
| NCT02559973 | Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder | COMPLETED | PHASE1 | 2015-09 | 2016-03 | 2016-02 |
| NCT02510014 | Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder | COMPLETED | PHASE3 | 2015-07-27 | 2017-01-31 | 2017-01-31 |
| NCT02357901 | Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine | COMPLETED | PHASE3 | 2015-01-28 | 2016-04-29 | 2016-04-29 |
| NCT02203838 | Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia | COMPLETED | PHASE3 | 2014-06 | 2016-09 | 2016-09 |
| NCT02109562 | Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients | COMPLETED | PHASE3 | 2014-04 | 2014-11 | 2014-11 |
| NCT02044094 | Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder | COMPLETED | PHASE2 | 2013-11 | 2014-07 | 2014-07 |
| NCT02038790 | Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population | COMPLETED | PHASE4 | 2013-11 | 2013-11 | 2013-11 |
| NCT01846481 | A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse | COMPLETED | PHASE2 | 2013-04 | 2013-06 | 2013-06 |
| NCT01738503 | Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects | COMPLETED | PHASE2 | 2012-10 | 2014-05 | 2014-05 |
| NCT01846455 | Single Dose Pharmacokinetics of Suboxone Study in Hepatic Impaired Subjects | COMPLETED | PHASE4 | 2012-09 | 2013-05 | 2013-04 |
| NCT01677377 | Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy | COMPLETED | PHASE2 | 2012-08 | 2013-04 | 2013-04 |
| NCT03002961 | Single Ascending Dose Study of RBP-6000 | COMPLETED | PHASE1 | 2012-07 | 2013-10 | 2013-02 |
| NCT01582347 | Transfer of Subjects From Subutex/Suboxone to RBP-6300 | COMPLETED | PHASE2 | 2012-03 | 2012-11 | 2012-11 |
| NCT02768649 | Single Ascending Dose Study of RBP-7000 | COMPLETED | PHASE1 | 2011-04 | 2012-02 | 2012-02 |
| NCT02765867 | Single-dose, Study of RBP-6000 in Opioid Dependent Individuals | COMPLETED | PHASE1 | 2010-11 | 2011-05 | 2011-05 |
| NCT02765555 | First in Man Study of Safety, Tolerability and PK Profile of RBP-7000 | COMPLETED | PHASE1 | 2010-03 | 2010-09 | 2010-09 |
| NCT00955162 | Effectiveness of Buprenorphine/Naloxone in Reducing Intravenous Buprenorphine Misuse in France ("RIME") | COMPLETED | PHASE4 | 2009-08 | 2011-05 | 2010-05 |
| NCT00901875 | Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan | COMPLETED | PHASE4 | 2009-03 | 2010-01 | 2009-11 |
| NCT00637000 | Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone | COMPLETED | PHASE2 | 2008-03 | 2008-09 | 2008-09 |
| NCT00605033 | A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) | COMPLETED | PHASE4 | 2008-03 | 2009-05 | 2009-04 |
| NCT00640835 | Safety and Tolerability of Buprenorphine/Naloxone Film Strips | COMPLETED | PHASE2 | 2008-02 | 2008-10 | 2008-10 |
| NCT00684073 | Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) | COMPLETED | PHASE4 | 2007-07 | 2007-12 | 2007-12 |
| NCT00838396 | A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease | COMPLETED | PHASE2 | 2005-10 | 2006-08 | 2006-08 |
| NCT01075971 | Study of Two Formulations of Buprenorphine HCl in Opioid-dependent Subjects on Buprenorphine Maintenance Therapy (Study P04451) (COMPLETED) | COMPLETED | PHASE2 | 2005-09 | 2005-11 | 2005-11 |
| NCT00279565 | Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED) | TERMINATED | PHASE4 | 2005-08 | 2007-02 | 2007-02 |